NCT02737267

Brief Summary

This study evaluates the relationship between several genetic variants and the response to a hypocaloric diet, in order to design a genetic test which permits prescribe the more personalized diet for each individual according to her genotype. Half of the participants will assigned to a moderate high protein diet, while the other half will assigned to a high carbohydrate diet.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 10, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 13, 2016

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

March 29, 2017

Status Verified

November 1, 2015

Enrollment Period

2.1 years

First QC Date

March 10, 2016

Last Update Submit

March 28, 2017

Conditions

Keywords

GeneticsPolymorphismEpigeneticsMetagenomicsMetabolomicsMetabolic syndrome conditionsPrecision nutrition

Outcome Measures

Primary Outcomes (2)

  • Change in body weight at Week 16

    Baseline and 16 Weeks

  • Change in body weight at Week 40

    16 Weeks and 40 Weeks

Secondary Outcomes (92)

  • Height

    Baseline

  • Change in waist and hip circumferences at 16 Weeks

    Baseline and 16 Weeks

  • Change in waist and hip circumferences at 40 Weeks

    16 Weeks and 40 Weeks

  • Change in body fat mass at 16 Weeks

    Baseline and 16 Weeks

  • Change in body fat mass at 40 Weeks

    16 Weeks and 40 Weeks

  • +87 more secondary outcomes

Study Arms (2)

Moderately high protein diet

EXPERIMENTAL

Caloric restriction (-30% total energy intake) Macronutrient distribution: 40% of the energy derived from carbohydrates, 30% of the energy derived from protein and 30% of the energy derived from fat

Behavioral: Moderately high protein diet

Low fat diet

PLACEBO COMPARATOR

Caloric restriction (-30% total energy intake) Macronutrient distribution: 60% of the energy derived from carbohydrates, 18% of the energy derived from protein and 22% of the energy derived from fat

Behavioral: Low fat diet

Interventions

After the recruitment randomization of the study participants, the study will consists of a 4-month nutritional intervention ("body weight loss period") followed by a second 6-month period ("body weight maintenance period") in which the subjects of the study will continue with the assigned diet, but without any energy restriction.

Moderately high protein diet
Low fat dietBEHAVIORAL

After the recruitment randomization of the study participants, the study will consists of a 4-month nutritional intervention ("body weight loss period") followed by a second 6-month period ("body weight maintenance period") in which the subjects of the study will continue with the assigned diet, but without any energy restriction.the energy derived from fat

Low fat diet

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Body Mass Index (BMI) between 25 and 40 kg/m2
  • Physical examination and vital signs normal, or is considered abnormal, but clinically insignificant by researcher.

You may not qualify if:

  • BMI less than 25 or higher than 40 kg/m2
  • Pregnant women
  • Breastfeeding period. If artificial feeding until 6 months after birth.
  • Type 1 diabetes
  • Severe kidney diseases
  • Severe digestive system diseases
  • Electrolyte disorders (disorders of sodium, potassium, calcium, chlorine, phosphorus, magnesium)
  • Acute cardiovascular diseases
  • Cancer
  • Anemia
  • Eating disorders
  • Recent prescription drug treatment (without stable doses scheduled)
  • Drug therapy that can influence weight loss as corticosteroids.
  • Some type of cognitive impairment and / psychic
  • Subjects in which poor collaboration or, in the investigator's opinion, have difficulty following the procedures of the study is foreseen
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Nutrition Research, University of Navarra

Pamplona, Navarre, 31008, Spain

Location

Related Publications (5)

  • Garcia-Alvarez NC, Riezu-Boj JI, Martinez JA, Garcia-Calzon S, Milagro FI. A Predictive Tool Based on DNA Methylation Data for Personalized Weight Loss through Different Dietary Strategies: A Pilot Study. Nutrients. 2023 Dec 6;15(24):5023. doi: 10.3390/nu15245023.

  • Cuevas-Sierra A, Milagro FI, Guruceaga E, Cuervo M, Goni L, Garcia-Granero M, Martinez JA, Riezu-Boj JI. A weight-loss model based on baseline microbiota and genetic scores for selection of dietary treatments in overweight and obese population. Clin Nutr. 2022 Aug;41(8):1712-1723. doi: 10.1016/j.clnu.2022.06.008. Epub 2022 Jun 16.

  • Cuevas-Sierra A, Romo-Hualde A, Aranaz P, Goni L, Cuervo M, Martinez JA, Milagro FI, Riezu-Boj JI. Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention. Eur J Nutr. 2021 Sep;60(6):3279-3301. doi: 10.1007/s00394-021-02508-0. Epub 2021 Feb 16.

  • Ramos-Lopez O, Cuervo M, Goni L, Milagro FI, Riezu-Boj JI, Martinez JA. Modeling of an integrative prototype based on genetic, phenotypic, and environmental information for personalized prescription of energy-restricted diets in overweight/obese subjects. Am J Clin Nutr. 2020 Feb 1;111(2):459-470. doi: 10.1093/ajcn/nqz286.

  • Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Goni L, Cuervo M, Martinez JA. Differential lipid metabolism outcomes associated with ADRB2 gene polymorphisms in response to two dietary interventions in overweight/obese subjects. Nutr Metab Cardiovasc Dis. 2018 Feb;28(2):165-172. doi: 10.1016/j.numecd.2017.11.006. Epub 2017 Dec 5.

MeSH Terms

Conditions

Body Weight Changes

Interventions

Diet, Fat-Restricted

Condition Hierarchy (Ancestors)

Body WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • J. Alfredo Martínez, MD, PhD

    Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain

    PRINCIPAL INVESTIGATOR
  • Fernando J. Corrales, PhD

    CIMA, University of Navarra

    PRINCIPAL INVESTIGATOR
  • Femín I Milagro, PhD

    Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain

    STUDY CHAIR
  • Jose Ignacio Riezu, PhD

    Centre for Nutrition Research, University of Navarra

    STUDY CHAIR
  • Carlos González-Navarro, PhD

    Centre for Nutrition Research, University of Navarra

    STUDY CHAIR
  • Marta Cuervo, PhD

    Centre for Nutrition Research, University of Navarra

    STUDY CHAIR
  • Iosune Zubieta

    Centre for Nutrition Research, University of Navarra

    STUDY CHAIR
  • Blanca Esther Martínez de Morentin, MD

    Centre for Nutrition Research, University of Navarra

    STUDY CHAIR
  • Leticia Goñi

    Centre for Nutrition Research, University of Navarra

    STUDY CHAIR
  • Santiago Navas, PhD

    Centre for Nutrition Research, University of Navarra. CIBER Obesity and Physiopathology of Nutrition (CIBERobn), Institute of Health Carlos III Madrid Spain

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2016

First Posted

April 13, 2016

Study Start

November 1, 2015

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

March 29, 2017

Record last verified: 2015-11

Data Sharing

IPD Sharing
Will not share

Locations